Archives

by in
Entry Author Date Location
Blaze Bioscience Snags $9M More to Take “Tumor Paint” to the Clinic 12/03/13 Seattle
NPR Highlights Seattle’s Pediatric Cancer Innovator, Jim Olson 09/13/13 Seattle
Hutch’s “Project Violet” Taps Crowd, Seeks $20M for Drug Discovery 08/15/13 Seattle
Presage Snags $13M from Celgene to Pick Winning Cancer Drug Combos 03/05/13 Seattle
Blaze Bioscience Caps Off $8.5M Financing, Charges Toward Clinic 02/22/13 Seattle
Fred Hutch Spinoff Blaze Bioscience Pulls in $5M For ‘Tumor Paint’ 06/08/12 Seattle
Presage Looks to Help Millennium Pick Cancer Drug Winners Early 04/06/12 Seattle
Hutch Spinoff Presage Biosciences Shuffles Management 12/15/11 Seattle
Blaze Bioscience, Fred Hutch Spinoff with Zymo Vet at the Helm, Seeks to “Paint” Tumors 10/18/11 Seattle
PhaseRx Angles for a Deal, Tom Clement’s New Device Gig(s), InDi’s Alzheimer’s Plan, & More in the Life Science Innovation Northwest Wrap-Up 03/04/11 Seattle
Presage Biosciences, the Fred Hutch Spinoff, Adds CEO, Angel Bucks, Big Pharma Customers 06/23/10 Seattle
Google Apps Teams Up with Local Firms, Evri and Twine Merge, WildTangent Goes Social, & More Seattle-Area Deals News 03/16/10 Seattle
Presage, a Hutch Spinoff, Raises $3M From Angels to Boost Cancer Drug Hit Rate 03/16/10 Seattle
Dendreon’s Manufacturing Challenge, Archus Cuts Deep, Accelerator Company Launches & More Seattle-Area Life Sciences News 05/21/09 Seattle
Presage, Fred Hutch Spinoff, Aims to Show Docs Which Cancer Drugs Work, and Which Won’t 05/19/09 Seattle
Page 1 of 1